About

Markus Goldinger is the Senior Director of Process Development at SHL Medical located in Taiwan. He joined SHL in 2017 as Senior Manager in Process Development, where he was responsible for project engineering, moulding process development and assembly process development. In late 2018 he also took over component development, including metal, packaging and printing process development. Before his current role, Mr Goldinger took directorship of process development in early 2019. In this position, he successfully restructured and guided his team towards SHL Medical’s high-volume production strategy.

Contributions

INJECTION

FROM PROCESS TO PRODUCT: OPTIMISING PROCESS DEVELOPMENT STRATEGIES FOR VARIABLE DRUG-DEVICE REQUIREMENTS

Markus Goldinger and Erik Alexandersson discuss the benefits to process development provided by SHL’s fully in-house, vertically integrated model, and how those benefits are applied throughout the process from initial design work to final assembly of the drug delivery device and primary container.